首页 >
法规速递
-
Document: List of eligible industry stakeholder organisations-2025/1/23
2025-01-23查看详情 > -
Document: Procedural advice for orphan medicinal product designation: Guidance for sponsors-2025/1/23
2025-01-23查看详情 > -
Document: European Medicines Agency’s data protection notice for meeting registration forms via EUSurvey-2025/1/23
2025-01-23查看详情 > -
Page: Parallel scientific advice processes and special product types-2025/1/22
2025-01-23查看详情 > -
Document: Dates of 2025 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests-2025/1/22
2025-01-23查看详情 > -
Document: CHMP and Rapporteurs' assessment report template on Similarity Rev. 03.23-2025/1/22
2025-01-23查看详情 > -
Page: Accelerating Clinical Trials in the EU (ACT EU)-2025/1/22
2025-01-23查看详情 > -
Document: Appendix 1: Acceptable intakes established for N-nitrosamines-2025/1/22
2025-01-23查看详情 > -
Document: Innovation Task Force (ITF) briefing meeting request form-2025/1/22
2025-01-23查看详情 > -
Document: Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)-2025/1/22
2025-01-23查看详情 >